Skip to main content
. 2020 Jan 27;64(2):e02102-19. doi: 10.1128/AAC.02102-19

FIG 2.

FIG 2

Mean log10 CFU/ml versus time profile for each isolate against fosfomycin-laden urine collected from subjects during the QOD dosing regimen on day 5 without G6P (A) and with 25 mg/liter G6P (B) and during the QD dosing regimen on day 5 without G6P (C) and with 25 mg/liter G6P (D). Curves represent average concentrations for triplicate experiments. The y axis is in the log scale.